Arvinas, INC Form 4 insider transactions

NASDAQ

21 Mar 2024

ARVN

Form 4: Arvinas Inc. Executive Noah Berkowitz Reports Stock and Option Grants

Chief Medical Officer Noah Berkowitz of Arvinas Inc. reports the acquisition of restricted stock units and stock options granted on March 18, 2024.

NASDAQ

27 Feb 2024

ARVN

Arvinas, INC

Form 4: Arvinas CEO John Houston Reports Stock Transactions

Arvinas CEO John Houston reports acquisition of restricted stock units and stock options, as well as the sale of shares to cover withholding taxes.

NASDAQ

27 Feb 2024

ARVN

Arvinas, INC

Form 4: Arvinas CFO Sean Cassidy Sells Shares to Cover Tax Obligations

Sean Cassidy, CFO of Arvinas, Inc., sold 1,702 shares of common stock on February 23, 2024, to cover withholding taxes related to the vesting of restricted stock units.

NASDAQ

27 Feb 2024

ARVN

Arvinas, INC

Form 4: Arvinas Inc. Officer Ronald Peck Reports Stock Transactions

Chief Medical Officer Ronald Peck of Arvinas, Inc. reports acquisition and disposal of common stock and stock options.

NASDAQ

27 Feb 2024

ARVN

Arvinas, INC

Form 4: Arvinas' Chief Scientific Officer, Ian Taylor, Reports Stock Transactions and New Stock Option Grant

Ian Taylor, Chief Scientific Officer of Arvinas, Inc., reports acquisition of restricted stock units and stock options, as well as the sale of shares to cover withholding taxes.

NASDAQ

27 Feb 2024

ARVN

Arvinas, INC

Form 4: Arvinas Inc. Chief Accounting Officer David K. Loomis Reports Stock and Option Awards

David K. Loomis, Chief Accounting Officer of Arvinas Inc., reports the acquisition of restricted stock units and stock options, along with the disposition of common stock.